首页>
外国专利>
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
展开▼
机译:较低剂量强度的咪喹莫特制剂和短剂量方案,用于治疗生殖器和肛周疣
展开▼
页面导航
摘要
著录项
相似文献
摘要
Pharmaceutical formulations and methods for the topical or transdermal delivery of 1isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine or 1-(2-methylpropyl)-1H-imidazo[4,5 c]quinolin-4-amine, i.e., imiquimod, to treat genital/perianal warts with shorter durations of therapy than currently prescribed for the commercially available for Aldara® 5% imiquimod cream, as now approved by the U.S. Food & Drug Administration (“FDA”), are disclosed and described. More specifically, lower dosage strength imiquimod formulations to deliver an efficacious dose of imiquimod for treating genital/perianal warts with an acceptable safety profile and dosing regimens that are shorter and more convenient for patient use than the dosing regimen currently approved by the U.S. Food & Drug Administration (“FDA”) for Aldara® 5% imiquimod cream to treat genital/perianal warts are also disclosed and described.
展开▼